🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05972070
Recruiting Observational

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

NCT05972070 · tracked via the Priya Life Science USA tracker
Sponsor
ROM Technologies, INC
Phase
Observational
Started
2023-06-01
Last updated
2025-07-24

Condition(s) studied

Myocardial InfarctionPercutaneous Transluminal Coronary AngioplastyCoronary Artery BypassStable AnginaHeart FailureValve Disease, HeartCardiac RehabilitationStent

Investigational drug(s) / intervention(s)

ROMTech Portable Connect

ROMTech Portable Connect: The ROMTech PortableConnect Rehab System is a continuous rehabilitative exercise therapy device that uses assisted movement to measure, evaluate, exercise, re-educate and strengthen muscles, and to increase joint range of motion.

Study summary

The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Over the age of 18 2. NYHA Functional Class I, II, 3. Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation) 4. Candidate for traditional center-based cardiac rehabilitation Exclusion Criteria: 1. Under the age of 18 2. Adults lacking capacity to consent. 3. NYHA Functional Class III, IV 4. Acute coronary syndrome 5. Systolic heart failure (LV EF \<40%) 6. Status post cardiac surgery for structural heart disease or heart transplant 7. Percutaneous coronary angioplasty 8. Adults lacking capacity to consent. 9. Pregnant women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ROMTech Brookfield Connecticut Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05972070 on ClinicalTrials.gov ↗ ← All trials in the USA